Multiply Labs With Legend Biotech Announces A Collaboration On Automating Cell Therapy Manufacturing
Portfolio Pulse from Benzinga Newsdesk
Multiply Labs and Legend Biotech have announced a collaboration to automate cell therapy manufacturing using advanced robotic technology. This partnership aims to enhance the efficiency and adoption of robotic systems in the cell and gene therapy industry.
September 24, 2024 | 1:10 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Legend Biotech has partnered with Multiply Labs to automate cell therapy manufacturing using advanced robotics. This collaboration could enhance manufacturing efficiency and accelerate the adoption of robotic systems in the industry.
The collaboration with Multiply Labs is likely to enhance Legend Biotech's manufacturing capabilities, potentially leading to increased efficiency and cost savings. This could positively impact Legend Biotech's market position and stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90